🔎 Trials Near Me

Home › Respiratory Syncytial Virus Infections

Respiratory Syncytial Virus Infections clinical trials recruiting in the U.S.

7 studies for Respiratory Syncytial Virus Infections are recruiting participants at sites across the United States.

Respiratory syncytial virus (RSV) causes cold-like symptoms in adults and healthy children but can cause serious problems in babies. Read more.

Cities with the most studies

By state

Recently updated studies

Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

RecruitingObservational study
12 Months · All sexes · Updated Oct 23, 2026 · NCT06172660

A Study of BLB-201 RSV Vaccine in Infants and Children

RecruitingPhase 1/2Healthy volunteers welcome
6 Months – 5 Years · All sexes · Updated Oct 21, 2026 · NCT05655182

A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose

RecruitingPhase 3Healthy volunteers welcome
Ages 0 and older · All sexes · Updated Oct 14, 2026 · NCT06866405

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06817889

Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children

RecruitingPhase 3
3 Days – 2 Years · All sexes · Updated Feb 9, 2026 · NCT05026749

Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults

RecruitingPhase 1Healthy volunteers welcome
Ages 60 to 85 · All sexes · Updated May 14, 2025 · NCT06843317

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.